Breast Cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Breast Cancer
Jun 14, 2025, 05:22 | Blog
Yan Leyfman: New Study Alert - CAFs vs NK Cells in Breast Cancer
Yan Leyfman, Co-founder and Executive Director of MedNews Week, posted on X: "New Study Alert:…
Jun 13, 2025, 22:18 | Blog
Sally Wolf Speaks Out on Healthcare Inequities Impacting Young Breast Cancer Patients
Sally Wolf, CEO and Founder of LightWorks, shared a post on LinkedIn: "MTV VJ Ananda…
Jun 13, 2025, 15:43 | Oncolibrary
New Paper Alert: NRG‑NSABP B‑51/RTOG 1304 Trial on Regional Nodal Irradiation Omission in ypN0 Breast Cancer After Neoadjuvant Chemotherapy
Regional nodal irradiation (RNI) is standard for breast cancer patients with pathologically positive axillary lymph…
Jun 13, 2025, 07:28 | Science
QoL Findings from PALLAS Trial are Published in ESMO Open - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X about a paper by M.J. Naughton…
Jun 13, 2025, 06:33 | Blog
Fatima Cardoso Joins Panel at World Cancer Series Europe to Spotlight Women-Centric Cancer Policy - ABC Global Alliance
ABC Global Alliance posted on X: "Our President, Fatima Cardoso, joined a powerful panel Economist…
Jun 13, 2025, 05:57 | Science
Dana-Farber’s Breast Oncology Center - Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients
Dana-Farber’s Breast Oncology Center posted on X: "New study evaluates the accuracy and reproducibility of…
Jun 12, 2025, 18:30 | Blog
ESMO Daily Reporter Interviewed Paolo Tarantino on ADCs in Breast Cancer Care
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Recent study results…
Jun 12, 2025, 17:47 | Blog
Mark Lewis: It’s Only "Practice-Changing" If Patients See Benefit and Are Willing to Act Post-ASCO25
Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, shared a post on…
Jun 12, 2025, 17:42 | Blog
The Max Foundation Highlighted Satish Tulsidás and Breast Cancer Care at Central Hospital of Maputo in Mozambique
The Max Foundation shared a post on LinkedIn: "Welcome to a monthly feature spotlighting one…
Jun 12, 2025, 13:48 | Celebrities
Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More
Linda Evangelista, one of the greatest supermodels of the 1990s and a fashion icon known…
Jun 12, 2025, 11:21 | Blog
Applications are Open for the ESO's Certificate of Competence in Breast Cancer - Sixth Cohort
European School of Oncology posted on LinkedIn: "Applications are open for the Certificate of Competence…
Jun 12, 2025, 09:57 | Blog
Sergio Cifuentes Canaval: Immuno-oncology in Breast Cancer - Progress, Gaps, and Research Opportunities
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on LinkedIn:…
Jun 11, 2025, 13:48 | Career
Robert Bard Has Been Appointed as a Chair of Clinical Diagnostics at MBCGA
Cheri Ambrose, Founder of Male Breast Cancer Global Alliance (MBCGA), shared a post on LinkedIn:…
Jun 11, 2025, 11:45 | Blog
Breast Cancer Diagnoses In Women Under 50 Are Rising and Are Often More Aggressive - BCRF
The Breast Cancer Research Foundation shared a post on LinkedIn: "Breast cancer diagnoses in women…
Jun 11, 2025, 11:32 | Insight
Goutham Sunny: A very important editorial on tailoring treatment for older individuals with favourable breast cancer
Goutham Sunny, Former Resident Doctor at The Gujarat Cancer and Research Institute, shared a post…
Jun 11, 2025, 08:06 | Blog
Breast Cancer Research Foundation Shares Inspirational Quotes for Patients at Every Stage
The Breast Cancer Research Foundation shared a post on LinkedIn: "These powerful quotes from breast…
Jun 11, 2025, 05:56 | Blog
Alisher Kahharov: Just Attended the MIB Meeting in Paris
Alisher Kahharov, Associate Professor of Oncology at Tashkent Medical Academy, shared a post on Facebook:…
Jun 11, 2025, 04:57 | Blog
Olubukola Ayodele: Spotlight on Breast Cancer - Cancer Conversations in the Black Community
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a…
Jun 10, 2025, 22:40 | Blog
Olubukola Ayodele: Fighting Cancer Misinformation - Myths and Facts
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, posted on…
Jun 10, 2025, 19:16 | Insight
Francisco J. Esteva: Can PROTACs Beat ESR1 Mutations in Breast Cancer?
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 10, 2025, 12:02 | Blog
Zainab Shinkafi-Bagudu: Early Detection Through Regular Breast Examinations Saves Lives
Zainab Shinkafi-Bagudu, UICC President-Elect of 2024-2026 and a Founder of the Medicaid Cancer Foundation, posted…
Jun 10, 2025, 08:21 | Blog
Armando Orlandi: NEJM Study Challenges Regional Nodal Irradiation in Breast Cancer
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post…
Jun 9, 2025, 18:05 | Science
Armando Orlandi Evaluates CDK4/6 Inhibitors in Adjuvant Breast Cancer Using NNT Metric
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post…
Jun 9, 2025, 15:27 | Insight
Paolo Tarantino: Interesting Phase 2 Trial of 1L Treatment for PDL1- mTNBC Out in Nature Medicine
Paolo Tarantino, 2025 Yvonne ‘Top Voice’ Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared…
Jun 9, 2025, 09:26 | Blog
Sherene Loi: Neoadjuvant Atezolizumab in Early TNBC
Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer…
Jun 9, 2025, 08:42 | Blog
Rob Winn: Science Saves Lives, and at Massey, We’re Making Sure it Saves Every Life it can
Rob Winn, Director and Lipman Chair in Oncology at VCU Massey Comprehensive Cancer Center and a…
Jun 9, 2025, 07:07 | Blog
Paolo Tarantino Raises Poll on Chemotherapy Attrition in Metastatic Breast Cancer
Paolo Tarantino, 2025 Yvonne ‘Top Voice’ Award Winner, Research Fellow at Dana-Farber Cancer Institute, posted…
Jun 8, 2025, 16:55 | Insight
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of…
Jun 8, 2025, 09:03 | Blog
Jason Mouabbi and Paolo Tarantino Discuss How T-DXd + Pertuzumab Could Reshape Frontline Treatment in HER2+ mBC
Community Health Media shared a post on X: "At ASCO25, first results from DESTINY-Breast09 (DB09)…
Jun 8, 2025, 07:45 | Positive
Matteo Lambertini: Grateful for Another Successful YBO Event in Beautiful Genova
Matteo Lambertini, Associate Professor at the University of Genova, shared a post on X: "Really…
Jun 8, 2025, 00:15 | Blog
Maryam Lustberg: Free Virtual Nutrition Support for Triple Negative Breast Cancer Patients in the USA
Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale…
Jun 7, 2025, 14:53 | Blog
Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn: "Treatment…
Jun 7, 2025, 14:38 | Insight
Paolo Tarantino: Thanks to NSABP-B51, Countless Patients Will Be Spared the Toxicity of Nodal Irradiation
Paolo Tarantino, 2025 Yvonne 'Top Voice' Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared…
Jun 7, 2025, 12:23 | Blog
Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO
Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared a post…
Jun 7, 2025, 10:35 | Blog
SOFT and TEXT Trials Are The Result of Over 20 Years of Collaboration - Breast International Group
Breast International Group shared a post on X: "SOFT and TEXT trials are the result…
Jun 7, 2025, 06:12 | Blog
Francisco J. Esteva: Is ctDNA Ready to Guide Treatment in Real Time?
Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill…
Jun 6, 2025, 16:08 | Blog
Luca Arecco: Grateful to Attend The 5th Edition of The Young Breast Oncologists Meeting
Luca Arecco, Clinical Research Fellow at ESMO, shared a post on X: "Grateful to attend…
Jun 6, 2025, 15:43 | Blog
Douglas Flora: Fueling the Fight, Quality Woven In - Reflections After ASCO25
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post…
Jun 6, 2025, 12:40 | Blog
Fumiko Ladd Chino: How Doctors Can Help Address the Affordability Gap
Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X: "New…
Jun 6, 2025, 12:16 | Science
NEJM Reports Phase 3 Trial on Omitting Nodal Irradiation in Node-Positive Breast Cancer
NEJM shared a post on X: "In women with node-positive breast cancer whose nodes became free…
Jun 6, 2025, 08:20 | Blog
Ravi K. Gupta: Honored to Learn from Dr. Margaret Gatti-Mays at ASCO 2025 on Advancements in Breast Cancer Care
Ravi K. Gupta, Hematology-Oncology Fellow at Larkin Health System, shared a post on LinkedIn: "Thank…
Jun 6, 2025, 07:28 | Blog
Sibylle Loibl: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Sibylle Loibl, Chief Executive Officer of GBG Forschungs GmbH, shared a post on LinkedIn: "Breaking…
Jun 6, 2025, 05:24 | Blog
Julie Wierzbicki: ASCO 2025 Highlights - Liquid Biopsy and Advances in Small Cell Lung Cancer
Julie Wierzbicki, Journalist and editor at Pharmaceutiques, shared a post on LinkedIn: "Today on Pharmaceutiques.com,…
Jun 5, 2025, 10:49 | Science
Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States
Sakditad “Tew” Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X: "Proud…
Jun 5, 2025, 06:15 | Blog
Kleida Mati Has Been Awarded a Partial Scholarship to Pursue The Master’s in Molecular Oncology - European School of Oncology
European School of Oncology shared a post on LinkedIn: "We’re proud to announce that Kleida…
Jun 4, 2025, 23:12 | Insight
Erika Hamilton: Highlights on ASCO 2025 Day 4
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon…
Jun 4, 2025, 16:52 | Blog
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a…
Jun 4, 2025, 16:33 | Insight
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "With ASCO25…
Jun 4, 2025, 10:43 | Blog
The First-Ever AI Tool that Predicts a Woman’s Breast Cancer Risk over the following 5 year - The Breast Cancer Research Foundation
The Breast Cancer Research Foundation shared a post on LinkedIn: "The FDA just approved Clairity Breast,…
Jun 4, 2025, 10:02 | Blog
Establishing a Breast Cancer Program in Sierra Leone - The Max Foundation
The Max Foundation shared a post on LinkedIn: "Creating access to sustainable treatment and care…
Jun 4, 2025, 09:58 | Blog
Transformative study for 1st line Metastatic HER2+ Breast Cancer at ASCO25
Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared a…
Jun 4, 2025, 05:55 | Blog
Maryam Lustberg Reflects on ASCO 2025 and Looks Ahead to MASCC Meeting
Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale…
Jun 3, 2025, 18:29 | Insight
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Philippe Aftimos, Medical Oncologist at the Jules Bordet Institute, shared a post on LinkedIn: "At…
Jun 3, 2025, 16:58 | Insight
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared on…
Jun 3, 2025, 14:56 | Insight
Nick Turner on Targeting Breast Cancer Early with New Drug Camizestrant – ICR on SERENA-6 Trial at ASCO 2025
The Institute of Cancer Research shared a post on LinkedIn: "BREAKING NEWS A powerful new…
Jun 3, 2025, 13:46 | Insight
Sergio Cifuentes: DB-09 continues to demonstrate superiority in all treatment settings for HER2-positive MBC
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared on X: "DB-09 continues to…
Jun 3, 2025, 13:23 | Insight
Sarah Sammons: RLY2608 and Fulvestrant in HR+/HER2- PIK3CA mutant breast cancer
Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center, shared on…
Jun 3, 2025, 12:49 | Insight
Paolo Tarantino: Does scalp cooling work to prevent alopecia with T-DXd?
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared on…
Jun 3, 2025, 11:34 | Blog
Armando Orlandi: Time to Challenge the Paradigm - CDK4/6 Inhibitors in Visceral Crisis 
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn:…
Jun 3, 2025, 11:15 | Insight
Armando Orlandi: Day 4 at ASCO 2025 - Key Breast Cancer Clinical Advances 
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn: "Day 4:…
Jun 2, 2025, 21:29 | Blog
Elvina Almuradova: The SERENA-6 Trial Introduces a New Standard in ESR1-mutant ER+/HER2- Advanced Breast Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jun 2, 2025, 14:40 | Blog
The Complexities of HER2-low Disease and why Precision isn’t just about Biomarkers, it’s about Mindset - Community Health Media
Community Health Media shared a post on LinkedIn: "What happens when HER2-targeted therapies like T-DXd challenge…
Jun 2, 2025, 13:00 | Blog
Paolo Tarantino: Proud to be part of the Italian winners of the ASCO Conquer Merit Award 2025
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…
Jun 2, 2025, 11:55 | Blog
Stephanie Graff Highlights ASCENT-04 Results Supporting SG plus Pembrolizumab in TNBC
Stephanie Graff, Director of Breast Oncology at Brown University Health and an Associate Professor of Medicine…
Jun 2, 2025, 11:32 | Oncolibrary
DESTINY-Breast09 Trial: T-DXd Plus Pertuzumab Sets a New Benchmark in First-Line HER2-Positive Metastatic Breast Cancer
HER2-positive advanced or metastatic breast cancer (HER2+ a/mBC) remains a clinical challenge, despite major progress…
Jun 2, 2025, 08:57 | Science
Chris De Savi: New Winning Drugs in ER+ Breast Cancer
Chris De Savi, Chief Scientific Officer, Partner at Curie.Bio posted on LinkedIn: "New Winning Drugs…
Jun 2, 2025, 06:59 | Blog
Armando Orlandi: Day 3 of ASCO25 - Key Breast Cancer Updates
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn:…
Jun 1, 2025, 18:59 | Oncolibrary
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
At ASCO 2025, results presented by Turner Nicholas from the global Phase 3 SERENA-6 trial…
Jun 1, 2025, 16:52 | Blog
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on X:…
Jun 1, 2025, 16:36 | Insight
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer
Rebecca Shatsky, Breast Cancer Medical Oncologist at UCSD, shared on X: "It’s high time for…
Jun 1, 2025, 16:25 | Blog
Sarah Sammons: 50% of patients do not make it to second line therapy in mTNBC
Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center, shared on…
Jun 1, 2025, 16:16 | Insight
Shaheenah Dawood: Nice Summary of Three Oral Breast Abstracts Presented at ASCO 2025
Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn: "Nice…
Jun 1, 2025, 16:11 | Insight
Erika Hamilton Presented VERITAC-2 Results on Vepdegestrant at ASCO 2025
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon…
Jun 1, 2025, 16:06 | Insight
Jame Abraham Highlighted NEJM Study on Inavolisib Combo in PIK3CA-Mutated Advanced Breast Cancer
Jame Abraham, Chairman and Professor of the Department of Hematology and Medical Oncology at the…
Jun 1, 2025, 15:32 | Insight
Olubukola Ayodele on INAVO120 Inavolisib Combo Results at ASCO 2025
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, posted on…
Jun 1, 2025, 11:07 | Blog
Armando Orlandi: ASCO25 Breast Cancer Update, Early Data from May 30th Session
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on…
Jun 1, 2025, 10:57 | Oncolibrary
TUXEDO-3 Trial at ASCO 2025: HER3-DXd Shows Promising CNS Activity in Brain Metastases and Leptomeningeal Disease
Fresh from the podium at ASCO 2025, the TUXEDO-3 trial introduces a promising therapeutic strategy…
Jun 1, 2025, 10:03 | Blog
Matthew Kurian: Highlights from Day 1 at ASCO25’s Metastatic Breast Cancer Data that stood out
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared a…
Jun 1, 2025, 09:36 | Blog
Armando Orlandi: Historic PROTAC Milestone and Pivotal Phase 3 Results on ASCO25 Day 2
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on…
Jun 1, 2025, 07:22 | Blog
Paolo Tarantino: How Will Physicians Translate The Tesults of DESTINY-Breast09 Into Clinical Practice?
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared Community Health Media's post on LinkedIn,…
Jun 1, 2025, 06:27 | Blog
Alfonso Gómez de Liaño Highlights CREST Trial Insights in BCG-Unexposed Bladder Cancer at ASCO 2025
Alfonso Gómez de Liaño, Medical Oncologist at the Insular-Materno Infantil University Hospital Complex, posted on…
Jun 1, 2025, 05:46 | Blog
Olubukola Ayodele: Day 2 of ASCO2025
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, posted on…
Jun 1, 2025, 05:39 | Blog
Siobhan Freeney Calls on Minister for Health Jennifer Carroll MacNeill to Mandate Breast Density Reporting
Siobhan Freeney, Founder at Lobular Ireland, shared a post on LinkedIn: "With gratitude to OncoDaily…
Jun 1, 2025, 04:47 | Blog
National Cancer Institute of Kenya - Major Breakthrough in Breast Cancer Treatment Costs in Kenya
National Cancer Institute of Kenya posted on LinkedIn: "Major Breakthrough in Breast Cancer Treatment Costs…
Jun 1, 2025, 04:09 | Science
Akhil Kapoor: Real-World Evidence for T-DM1 in HER2+ Metastatic Breast Cancer from India Published in Nature
Akhil Kapoor, Professor, Medical Oncologist at TMH Varanasi, shared a post on LinkedIn: "Real-world evidence…
Jun 1, 2025, 03:54 | Oncolibrary
INAVO120 Trial Final OS Analysis: INAVO Plus Palbociclib and Fulvestrant Improves Survival in PIK3CA-Mutated HR+/HER2– Advanced Breast Cancer
The INAVO120 phase III trial (NCT04191499) evaluated INAVO (a potent and selective PI3Kα inhibitor that…
May 31, 2025, 17:47 | Insight
Praveen Kumar Marimuthu: Key Highlights from ASCO 2025 Day 1
Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared…
May 31, 2025, 15:09 | Stories
Lacy Hubbard Shared Breast Cancer Patient Story Highlighting Importance of Screening Initiatives in Rwanda
Lacy Hubbard, President of the Elekta Foundation, shared a post on LinkedIn: "Breast Cancer Screening: Works…
May 31, 2025, 14:02 | Science
Paolo Tarantino: The MSK Retrospective Experience With ADC Sequencing for MBC
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "The MSK…
May 31, 2025, 10:13 | Blog
Hesham ElGhazaly: Honored to have contributed to the development of the NCCN MENA Breast Cancer Guidelines
Hesham ElGhazaly, Elected President of the Executive Board at Egyptian Cancer Society, shared on LinkedIn: "I’m…
May 31, 2025, 06:31 | Opinion
Heidi Ko: Interesting Presentation During Metastatic Breast Cancer Session at ASCO 2025
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn: "Interesting…
May 31, 2025, 03:01 | Blog
Erika Hamilton: What Will We See at ASCO25 Breast Cancer Rapid Oral?
Erika Hamilton, Chair of Executive Committee Breast and Breast Program Lead at Sarah Cannon Research…
May 30, 2025, 15:37 | Blog
Elvina Almuradova: MSKCC Study Sheds Light on Treatment of HER2+ Node-Negative Breast Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
May 30, 2025, 15:00 | Blog
Fatima Cardoso Calls For a Comprehensive European Strategy on Genetic and Genomic Testing for Breast Cancer - TBCT
Transforming Breast Cancer Together shared a post on LinkedIn: "Belgium’s Cancer Diagnostics Lag Behind Belgium…
May 29, 2025, 12:53 | Blog
Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post…
May 29, 2025, 12:31 | Blog
European School of Oncology Launches Breast Cancer Refresher Course for Clinicians
European School of Oncology shared a post on LinkedIn: "Improve your clinical approach to breast cancer…
May 29, 2025, 10:44 | Blog
Francisco Esteva: Do all Breast Cancer Patients need Chemotherapy?
Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital…
May 29, 2025, 09:52 | Blog
Olubukola Ayodele: Self-Breast Examination Is The Most Effective Early Detection Tool We Have
Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared a…
May 28, 2025, 10:56 | Blog
City Cancer Challenge Launched Second Cycle of Cancer Medicines Access Program in Kumasi, Ghana
City Cancer Challenge shared a post on LinkedIn: "We are proud to announce the launch…
May 28, 2025, 10:44 | Blog
Lisa Larkin: National Cancer Survivor Day is Professionally and Personally Important to me
Lisa Larkin, Founder and CEO of Ms.Medicine, Founder and Executive Director of HERmedicine and President CEO…
All: 2178 Posts: 1 - 100
Special Coverage